Born has represented a Swedish company in the MedTech industry in international arbitration proceedings against a multi-national pharmaceutical group. In this case, Born worked closely with a third-party funder that supported the claimant in the proceedings.
Born successfully advised Stenhus Fastigheter i Norden AB (publ) in the refinancing of three group branches with different lenders. The transaction, with a combined loan amount of SEK 4,235 million, underscores Born’s deep expertise in complex real estate...
Born successfully advised Svensk FastighetsFinansiering AB (publ) for a bond issuance of SEK 196,000,000 through the company’s established MTN-program, representing an expansion of the existing green bond loan 154 scheduled to mature on 26 November 2029. The...
Born has advised Fabege AB (publ) on its sale of the Ynglingen 10 property to Stadsrum Fastigheter, at an underlying property value of SEK 960 million (prior to deferred tax deductions). The transaction involved a prominent mixed-use asset located at Karlavägen 58–60...
Born has advised Stenhus Fastigheter i Norden AB (publ) in connection with the listing of the company’s shares on the regulated market Nasdaq Stockholm. Trading in Stenhus Fastigheter’s shares on Nasdaq Stockholm, in the Mid Cap segment, commenced on 18 December 2024....
